Dashboard
Manage Tickers

ANIP


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

ani-pharmaceuticals-raises-fy2025-adj-eps-guidance-from-698-735-to-737-764-vs-728-est-raises-fy2025-sales-guidance-from-818000m-843000m-to-854000m-873000m-vs-844680m-est
ANI Pharmaceuticals Raises FY2025 Adj EPS ...
11/07/2025 11:54:19

ANI Pharmaceuticals (NASDAQ:ANIP) raises FY2025 Adj EPS guidance from $6.98-$7.35 to $7.37-$7.64 vs $7.28 analyst estimate. Rai...

ani-pharmaceuticals-q3-adj-eps-204-beats-175-estimate-sales-227813m-beat-211041m-estimate
ANI Pharmaceuticals Q3 Adj. EPS $2.04 Beat...
11/07/2025 11:51:28

ANI Pharmaceuticals (NASDAQ:ANIP) reported quarterly earnings of $2.04 per share which beat the analyst consensus estimate of $...

earnings-scheduled-for-november-7-2025
Earnings Scheduled For November 7, 2025
11/07/2025 11:11:23

examining-the-future-ani-pharmaceuticalss-earnings-outlook
Examining the Future: ANI Pharmaceuticals'...
11/06/2025 15:01:32

ani-pharma-to-highlight-results-from-new-day-clinical-trial-of-iluvien-019-mg-for-use-in-dme-patients-in-late-breaking-oral-presentation-during-retina-subspecialty-day-2025-at-aao-meeting
ANI Pharma To Highlight Results From NEW D...
10/16/2025 10:54:17

ANI Pharmaceuticals, Inc. ("ANI" or the "Company") (NASDAQ: ANIP) today announced that results from the NEW DAY...

truist-securities-maintains-hold-on-ani-pharmaceuticals-raises-price-target-to-90
Truist Securities Maintains Hold on ANI Ph...
10/09/2025 14:41:42

Truist Securities analyst Gregory Fraser maintains ANI Pharmaceuticals (NASDAQ:ANIP) with a Hold and raises the price target...

6-analysts-have-this-to-say-about-ani-pharmaceuticals
6 Analysts Have This To Say About ANI Phar...
09/24/2025 13:01:29

jp-morgan-maintains-overweight-on-ani-pharmaceuticals-raises-price-target-to-115
JP Morgan Maintains Overweight on ANI Phar...
09/24/2025 12:23:27

JP Morgan analyst Ekaterina Knyazkova maintains ANI Pharmaceuticals (NASDAQ:ANIP) with a Overweight and raises the price tar...

hc-wainwright--co-maintains-buy-on-ani-pharmaceuticals-raises-price-target-to-121
HC Wainwright & Co. Maintains Buy on ANI P...
09/17/2025 14:36:45

HC Wainwright & Co. analyst Brandon Folkes maintains ANI Pharmaceuticals (NASDAQ:ANIP) with a Buy and raises the price t...

4-analysts-have-this-to-say-about-ani-pharmaceuticals
4 Analysts Have This To Say About ANI Phar...
09/08/2025 20:00:28

guggenheim-maintains-buy-on-ani-pharmaceuticals-raises-price-target-to-114
Guggenheim Maintains Buy on ANI Pharmaceut...
09/08/2025 13:43:26

Guggenheim analyst Vamil Divan maintains ANI Pharmaceuticals (NASDAQ:ANIP) with a Buy and raises the price target from $86 t...

truist-securities-maintains-hold-on-ani-pharmaceuticals-raises-price-target-to-77
Truist Securities Maintains Hold on ANI Ph...
08/11/2025 13:18:18

Truist Securities analyst Gregory Fraser maintains ANI Pharmaceuticals (NASDAQ:ANIP) with a Hold and raises the price target...

hc-wainwright--co-maintains-buy-on-ani-pharmaceuticals-raises-price-target-to-93
HC Wainwright & Co. Maintains Buy on ANI P...
08/08/2025 18:57:07

HC Wainwright & Co. analyst Brandon Folkes maintains ANI Pharmaceuticals (NASDAQ:ANIP) with a Buy and raises the price t...

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
08/08/2025 12:08:44

ani-pharmaceuticals-raises-fy2025-adj-eps-guidance-from-627-662-to-698-735-vs-652-est-raises-fy2025-sales-guidance-from-768m-793m-to-818m-843m-vs-788076m-est
ANI Pharmaceuticals Raises FY2025 Adj EPS ...
08/08/2025 10:52:56

Full Year 2025 Guidance:Full Year 2025GuidancePrevious Full Year 2025Guidance2024 ActualGrowth Net Revenue (Total Company)$818 ...

ani-pharmaceuticals-q2-2025-adj-eps-180-beats-139-estimate-sales-211371m-beat-187797m-estimate
ANI Pharmaceuticals Q2 2025 Adj. EPS $1.80...
08/08/2025 10:51:06

Core News & Articles
Earnings Scheduled For August 8, 2025
08/08/2025 08:32:13

earnings-preview-for-ani-pharmaceuticals
Earnings Preview For ANI Pharmaceuticals
08/07/2025 15:04:36

Core News & Articles
Delaware Court Gives Unanimous Verdict Det...
07/29/2025 20:24:44

CG Oncology, Inc. (NASDAQ:CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a po...

ani-pharmas-iluvien-cuts-injections-for-diabetic-eye-disease-post-hoc-study-shows-fewer-shots-needed-than-aflibercept
ANI Pharma's ILUVIEN Cuts Injections for D...
07/23/2025 10:51:41

ANI Pharmaceuticals, Inc. (ANI or the Company) (NASDAQ:ANIP) today announced results from the NEW DAY clinical trial of ILUVIEN...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION